Related by context. All words. (Click for frequent words.) 72 Initiates Clinical Trial 71 Tyrosine Kinase Inhibitor 71 Treating Chronic 71 Replacement Therapy 71 Completes Patient Enrollment 71 Diabetic Neuropathy 71 Peripheral Arterial 70 Non Invasive Treatment 70 Phase Ib Clinical Trial 70 Diabetic Foot Ulcer 70 Meets Primary Endpoint 70 Investigational Treatment 70 FDA Approvals 70 Adjuvant Treatment 69 Rheumatoid 69 Heart Transplant Recipients 69 Phase IIb Trial 69 Patients Treated With 69 Allogeneic 69 Advanced Melanoma 69 Phase 2b Clinical Trial 69 Prolongs Survival 69 Patients Receiving 69 Shows Promise Against 69 Heart Failure Patients 69 Central Retinal Vein 68 Refractory Angina 68 Chronic Sinusitis 68 Drug Candidate 68 Catheter Associated 68 Initiate Clinical Trial 68 Improves Outcomes 68 Successfully Completes Phase 68 Ischemic 68 Clinical Trial Results 68 Demonstrates Efficacy 68 Topical Treatment 68 IND Application 68 Completes Enrollment 68 Fungal Infections 68 Phase III Pivotal 68 Myelodysplastic Syndromes 68 Phase III Trial 68 Skeletal Muscle 68 Phase 2a Trial 68 Allograft 68 Files IND 68 Delayed Graft Function 68 Immune Mediated 68 Acute Decompensated Heart Failure 68 HDL Selective Delipidation 68 Initiates Clinical 68 Dose Ranging Study 68 Initiates Phase II 68 Hepatocellular Carcinoma 68 Clinical Trial Evaluating 68 Transdermal Patch 68 Bucindolol 68 Patients Undergoing 68 FDA Okays 67 HDAC Inhibitor 67 Left Ventricular 67 Improve Survival 67 Schizophrenia Treatment 67 Phase III Clinical Trial 67 Achieves Primary Endpoint 67 Intravenous Formulation 67 Nicotine Vaccine 67 Rheumatoid Arthritis Patients 67 Diastolic Heart Failure 67 Diagnostic Tests 67 Confirmatory Phase 67 Biomarker Study 67 Slow Progression 67 Carotid 67 Novel Inhibitor 67 Initiates Phase III 67 Progenitor Cells 67 Adenoma 67 Interferon Alfa 67 Parathyroid Hormone 67 Drug Shows Promise 67 Acute Heart Failure 67 Artificial Pancreas 67 Efficacy Trial 67 Prevent Stroke 67 Preclinical Study 67 Patient Enrollment 67 Prospective Randomized 67 Beta Blocker 67 Shows Efficacy 67 Fallopian Tube 67 Adult Stem Cell Therapy 67 Cardiotoxicity 67 NDA Submission 67 Subtypes 67 Novel Therapeutic 67 Combo Therapy 67 Cholesterol Lowering Drug 67 Receives Orphan Drug Designation 67 Hypertriglyceridemia 67 Clinical Trial Data 67 Gets FDA Clearance 67 Lymphoid 67 Metabolic Disease 67 Metastatic Melanoma 67 Initiates Clinical Trials 67 Phase 2a Clinical Trial 67 Minimally Invasive Treatment 66 Drug Fails 66 lexidronam injection 66 Pulmonary Arterial Hypertension 66 Percutaneous Tibial Nerve Stimulation 66 Metabolic Disorder 66 Phase 2b Trial 66 Pivotal Trial 66 EVIZON TM 66 RhuDex 66 Parenteral Nutrition 66 Chemotherapy Induced 66 Initiates Enrollment 66 Pivotal Clinical Trial 66 Pivotal Study 66 Contrast Agent 66 Lung Cancer Drug 66 Neoadjuvant Chemotherapy 66 Adjuvant Chemotherapy 66 Immunosuppression 66 Intravitreal 66 Infarct 66 Corautus Genetics 66 Novel Compound 66 Chronic Heart Failure 66 Immunosuppressant 66 Differential Diagnosis 66 Progenitor Cell 66 Combination Treatment 66 Fondaparinux 66 Severe Sepsis 66 Autoimmune Disease 66 Endometrial Cancer 66 Reduces Mortality 66 Immunotherapeutic 66 Transdermal Delivery 66 Randomized Study 66 Enlarged Prostate 66 dual endothelin receptor antagonist 66 Eculizumab 66 Hypertrophy 66 Novel Oral 66 Mouse Model 66 See CLINICAL PHARMACOLOGY 66 Nonsurgical 66 Glucocorticoid 66 Novel Treatments 66 Protease Inhibitor 66 Treatment Reduces 66 Orthostatic Hypotension 66 Systemic Delivery 66 Dupuytren Contracture 66 Aurora Kinase 66 Node Positive 66 Intravascular 66 Investigational Drug 66 Prostatic 65 Thromboembolic 65 Novel Therapies 65 Initiates Phase 2b 65 Low Dose 65 Regenerative Cells 65 Minimally Invasive Procedure 65 Advanced Heart Failure 65 Antithrombin 65 Cell Transplant 65 Advanced Renal Cell 65 Angiotensin Converting Enzyme 65 MR Angiography 65 Milestone Payment 65 REMINDER ORLive Presents 65 Oral Mucositis 65 First Patient Enrolled 65 Motexafin Gadolinium 65 Radiation Induced 65 Risk Stratification 65 Breast Cancer Recurrence 65 Submits NDA 65 Lowers Risk 65 Files Investigational 65 Successfully Treats 65 GW# [003] 65 Pivotal Phase III 65 Contraindications 65 Liver Failure 65 Left Atrial 65 Pivotal Trials 65 Gene Linked 65 Less Invasive 65 Improves Survival 65 Squalamine 65 Oral Formulation 65 Drug Prevents 65 Dilated Cardiomyopathy 65 Adipose Derived Stem Cells 65 Neoplasms 65 Atopic Dermatitis 65 Oral Calcitonin 65 Inflammatory Markers 65 Spinal Fusion 65 Radioimmunotherapy 65 Granted Orphan Drug 65 Phase 2b Study 65 Hepatic Encephalopathy 65 Study Evaluating 65 Overactive Bladder 65 Phase IIa Clinical Trial 65 Anticancer Drug 65 Valvular Heart Disease 65 Arteriovenous 65 Stem Cell Treatment 65 AMPLATZER R 65 Dose Response 65 Valve Replacement 65 Cinacalcet 65 Cell Transplants 65 Inflammatory Arthritis 65 Diabetic Nephropathy 65 Vascular Grafts 65 Ischaemic 65 Demonstrates Positive 65 Psoriasis Drug 65 Disease Modifying 65 Proven Effective 65 Blood Pressure Drug 65 Autoimmune Diseases 65 Estrogen Receptor 65 Arterial Disease 65 Investigational Compound 65 Parathyroid 65 Patient Outcomes 65 Immune Tolerance 65 Myoblast Program 65 Microwave Ablation System 65 Catheter Ablation 65 Protease Inhibitors 65 Prophylactic Treatment 65 Hormone Refractory Prostate Cancer 65 Zenapax 65 Iron Overload 65 Kidney Function 65 Spinal Disc 65 Potent Inhibitor 65 Secondary Hyperparathyroidism 65 FDA Accepts 65 Lupus Drug 65 Improved Survival 65 catheter occlusion 65 Angiogenic 65 Thrombin 65 Begin Clinical Trials 65 Embolic Protection 65 Anti Tumor 65 Protein Linked 65 Surgical Treatment 65 JAK2 Inhibitor 65 Long Term Efficacy 65 Initiate Phase 65 Early Diagnosis 65 Renal Function 65 Pafuramidine 65 Demonstrates Significant 65 metastatic malignant 65 Statin Drugs 65 Fibrinogen 65 Clinical Outcome 65 FDA Clears 65 Soft Tissue Sarcoma 65 Antiviral Therapy 65 Subgroup Analysis 65 Thrombotic 65 ACE Inhibitors 65 Present Preclinical Data 64 Analytical Tool 64 JAK Inhibitor 64 Late Breaker 64 Mimetics 64 Phase IIb Clinical Trial 64 Oral Cavity 64 Renal Artery 64 Therapy Evaluation 64 Acute Renal Failure 64 Demonstrates Potential 64 Malignant Glioma 64 Tyrosine Kinase Inhibitors 64 Shows Statistically Significant 64 Cognitive Deficits 64 IV Busulfex 64 Prognostic Value 64 Diabetes Hypertension 64 Aflibercept 64 Muraglitazar 64 Demonstrates Sustained 64 ORLive Presents 64 Brain Metastases 64 Surgical Mesh 64 benign prostatic hypertrophy BPH 64 Interferon Gamma 64 Cyclooxygenase 2 64 Genes Linked 64 Liprotamase 64 Valopicitabine 64 Antiangiogenic 64 Bazedoxifene 64 Neovascularization 64 Patient Treated 64 Atypical Hemolytic Uremic Syndrome 64 Announce Collaboration Agreement 64 Factor VIIa 64 Hernia Repair 64 Fibroblast 64 Muscle Wasting 64 Critical Limb Ischemia 64 Tissue Engineered 64 Microvascular 64 Initiate Phase II 64 Montelukast 64 Circulatory Support 64 Effectively Treats 64 Reduced Risk 64 HCV Genotype 64 Genes Identified 64 Autologous 64 Placebo Controlled Study 64 Inflammatory Diseases 64 RNAi Therapeutic 64 IND Filing 64 Laryngeal Cancer 64 Mouse Models 64 Test Detects 64 Embolic Protection Device 64 SBIR Grant 64 Significantly Improves 64 Single Dose 64 Reperfusion Injury 64 Pooled Analysis 64 Coronary Artery Bypass Graft 64 Aliskiren 64 Medtronic CoreValve ® 64 Acute Ischemic Stroke 64 Ranolazine 64 Podium Presentation 64 Diamyd Medical Diamyd 64 Antithrombotic 64 Myocardial Ischemia 64 Glycosylation 64 Recurrent Breast Cancer 64 Hematopoietic 64 Supplemental Biologics License Application 64 Bronchodilator 64 Antigen Specific 64 Appears Safe 64 Knee Osteoarthritis 64 Therapy Shows Promise 64 Recombinant Human 64 Prolongs Life 64 Ischemia 64 Oral Spray 64 Carotid Artery Stenting 64 Peptic Ulcer 64 Bone Metastases 64 Rotavirus Vaccine 64 Hedgehog Pathway Inhibitor 64 Embolization 64 Asthma COPD 64 Galectin 3 64 Plaque Psoriasis 64 Urocortin 2 64 Bosutinib 64 Neo Bladder Augment 64 Hyperlipidemia 64 Predict Risk 64 Inhaled Insulin 64 Begins Dosing 64 Therapeutic Antibody 64 Prostate Cancer Vaccine 64 Aortic Valve 64 Temodar ® 64 Transplant Patients 64 Treated Patients 64 transthyretin TTR mediated amyloidosis 64 Adjunctive 64 Develop Novel 64 Personalized Immunotherapy 64 Romiplostim 64 Chronic Lymphocytic Leukemia 64 Licenses Novel 64 Announces FDA Clearance 64 Oral Fingolimod 64 Chemoradiation 64 Therapeutic Vaccine 64 Cardiomyocytes 64 Protein Involved 64 Transcatheter 64 Increased Mortality 64 Occlusive Disease 64 Pramlintide 64 GLP1 INT TM 64 Interferon Beta 64 Slows Progression 64 CT Angiography 64 Tumor Microenvironment 64 Non Alcoholic Fatty 64 Unmet Medical 64 Phase #b/#a clinical 64 Pulmonary Artery 64 Hypercholesterolemia 64 Bosentan 64 Presents Preclinical Data 64 Systemic Sclerosis 64 Acute Lung 64 Gout Drug 64 Lung Cancer Trial 64 Neuropathic 64 Elagolix 64 Monoclonal 64 Inhaled Corticosteroids 64 Ecallantide 64 Chronic Renal Failure 64 Lymphocytic 64 Invasive Fungal Infections 64 Hemorrhagic Stroke 64 Randomized Evaluation 64 uricase 64 Eluting Stent 63 Lupus Nephritis 63 Saforis 63 II Clinical Trial 63 Dupuytren Disease 63 Melphalan 63 AFRS TM 63 NASH Huntington 63 Drug Eluting Stent System 63 Immune Therapy 63 Aortic Aneurysm 63 PEGylated interferon 63 Statistically Significant 63 Inflammatory Disease 63 Deforolimus 63 Nuclear Receptors 63 Prostate Cancer Patients 63 Prospective Multicenter 63 IIa Clinical Trial 63 Decitabine 63 IL# PE#QQR 63 Benign Prostatic Hyperplasia BPH 63 Generic Versions 63 Abstract Accepted 63 Smooth Muscle 63 Breast Brachytherapy 63 Emerging Therapies 63 Stent Placement 63 Drug Eluting 63 Diagnostic Criteria 63 FDA Approves Drug 63 Epilepsy Drug 63 Chemokine Receptor 63 vapreotide acetate 63 Aggressive Reduction 63 Pneumococcal Vaccine 63 Disease Progression 63 Renal Cancer 63 HCV Protease Inhibitor 63 Proves Effective 63 ACE Inhibitor 63 Hormone Receptor Positive 63 Clinical Evaluation 63 Pemphigus 63 Glatiramer Acetate 63 allogeneic hematopoietic cell 63 Epidermal Growth Factor Receptor 63 Aortic Stenosis 63 Arthritis Drug 63 Blocked Arteries 63 #-# Full Text 63 Maven Semantic 63 Xyfid TM 63 Entry Inhibitor 63 Anticancer Agent 63 Non Alcoholic Steatohepatitis 63 Adult Growth Hormone 63 Lung Injury 63 Radiation Treatment 63 Drug Combo 63 Multiple Ascending Dose 63 Preclinical Data 63 Improve Diagnosis 63 Molecular Diagnostic Test 63 Helps Predict 63 Acute Kidney 63 Tezampanel 63 Diabetic Patients 63 Gene Mutation 63 Receive Milestone Payment 63 treat benign prostatic 63 Renal Cell Carcinoma 63 Thiazolidinediones 63 External Beam 63 Symptom Relief 63 Epratuzumab 63 Safinamide 63 acute peripheral arterial 63 Hepatic 63 Bayer Nexavar 63 Hip Fractures 63 Innate Immune 63 Total Knee Replacement 63 Nipent R 63 Uterine Cancer 63 DermTech International 63 Visceral Fat 63 Vaccine Adjuvants 63 Teva Provides Update 63 Septic Shock 63 ST Segment Elevation 63 thalidomide Thalomid 63 Guidelines Issued 63 Therapy Reduces 63 Antitumor Activity 63 Epithelium 63 Carotid Stenting 63 Tumor Response 63 abacavir Ziagen 63 Therapy Improves 63 Chemoprevention 63 Cancer Stem Cells 63 Novel Mechanism 63 Bioartificial Liver 63 Advanced Colorectal Cancer 63 Prostate Cancer Treatment 63 Pivotal Phase 63 Selective Cardiac Myosin Activator 63 Cryoablation 63 Shown Effective 63 Initiates Dosing 63 GATTEX TM 63 Reports Preclinical Data 63 Treatment Regimen 63 Announces Poster Presentations 63 chronic thromboembolic pulmonary 63 Randomized Phase 63 Fabry Disease 63 RENAL 63 Kidney Failure 63 Investigational Agent 63 Progressive Multifocal Leukoencephalopathy 63 Tumor Suppressor Gene 63 Aortic Dissection 63 Azacitidine 63 Bepreve TM 63 Kuvan R 63 Arrhythmogenic 63 Post Operative 63 Complicated Skin 63 Chronic Bronchitis 63 Liver Metastases 63 Retinoic Acid 63 Effective Treatments 63 CIMZIA TM certolizumab pegol 63 FS Antihemophilic Factor Recombinant 63 Stakeholder Opinions 63 Aromatase Inhibitors 63 Protein Synthesis 63 Preclinical Efficacy 63 Peripheral Vascular Disease 63 Abciximab 63 Artery Disease 63 Improve Outcomes 63 Receives CE Marking 63 LymphoStat B TM 63 Neuroprotection 63 Monoclonal antibody 63 EP #R 63 Multiple Myeloma MM 63 Thrombus 63 Retinal Vein Occlusion 63 Febuxostat 63 cystic fibrosis chronic pancreatitis 63 SYN# 63 Hematological Malignancies 63 Trigeminal Neuralgia 63 Interferon Alpha 63 Preimplantation 63 Tumor Progression 63 immunotherapeutic vaccine 63 Aortic Valve Replacement 63 Protease 63 Commences Phase 63 Liver Tumors 63 Irritable Bowel 63 Related Mortality 63 E1 INT TM 63 Intracerebral Hemorrhage 63 Beneficial Effects 63 Renal Failure 62 SomatoKine 62 chronic myocardial ischemia 62 Immune Cell 62 RHEO 62 Genetic Mutation 62 Corneal Transplant 62 Transplant Rejection 62 Kinase Inhibitors 62 Myelofibrosis 62 Tumor Growth 62 Acute Myocardial Infarction 62 Initiated Phase 62 Daclizumab 62 Idiopathic Pulmonary Fibrosis 62 Gene Variants 62 Urinary Tract Infections 62 Lung Cancer Survival 62 Pediatric Patients 62 ImmuKnow R 62 Hyperparathyroidism 62 Contrast Agents 62 NV1FGF 62 Novel Antibiotic 62 Torisel temsirolimus 62 Vitrasert R 62 HER2 Positive 62 Newly Diagnosed Multiple Myeloma 62 Kinase Inhibitor 62 Endarterectomy 62 Schizophrenia Drug 62 Neurological Disorder 62 Phase 1b Clinical Trial 62 Adjunctive Therapy 62 Combination REOLYSIN R 62 Acute Attacks 62 Myelodysplastic Syndrome MDS 62 Small Molecule 62 Oral Insulin 62 Gastric Cancer 62 Hsp# Inhibitor 62 Combination Therapy 62 Prenatal Diagnosis 62 Medoxomil 62 transcranial Doppler ultrasound 62 LPLD 62 Immunomodulatory 62 Ventilator Associated 62 Kidney Transplant Patients 62 Cervical Spine 62 Left Atrial Appendage 62 Pegloticase 62 Muscle Cells 62 Hematological 62 HuMax TAC 62 Biolimus A9 62 cromolyn sodium 62 Fibrin Sealant 62 Cytochrome P# 62 Genetic Markers 62 Inhaled Nitric Oxide 62 SinuNase TM 62 Myelodysplastic Syndrome 62 Radiofrequency Ablation RFA 62 Neurogenic 62 Severe Asthma 62 Treatment Shows Promise 62 Vascular Graft 62 Ocrelizumab 62 Detection Device 62 Rheumatoid Arthritis Drug 62 aurora kinase 62 Predict Response 62 Receives Milestone Payment 62 Is Well Tolerated 62 nonhuman primate model 62 First Patient Treated 62 Dalbavancin 62 Prognostic Significance 62 Peripheral Blood 62 RNAi Therapeutics 62 Antiplatelet 62 Protein Expression 62 Atherosclerotic 62 Small Bowel 62 Respiratory Distress 62 Reduces Risk 62 Systemic Lupus Erythematosus SLE 62 Reduces Pain 62 Lung Tumors 62 Targeted Therapies 62 Resistant Hypertension 62 fosbretabulin 62 Clostridium difficile Infection 62 Newly Diagnosed 62 Collaborators Present 62 treat chronic sinusitis 62 Fully Covered Stent 62 CONTRAINDICATIONS 62 Elderly Patients 62 kidney urologic 62 Drug Coated Stent 62 Mycophenolate Mofetil 62 First Patient Dosed 62 Confirms Efficacy 62 Leukemias 62 Hypertensive Patients 62 PEGylated Fab fragment 62 POSIDUR TM 62 Therapeutic Antibodies 62 Intra arterial 62 Posaconazole 62 atypical hemolytic uremic syndrome 62 Clinical Efficacy 62 Treat Parkinson Disease 62 Naive Patients 62 FDA APPROVES 62 Gastrointestinal Disorders 62 Recombinant Protein 62 myelodysplastic myeloproliferative diseases 62 Heterozygous Familial Hypercholesterolemia 62 Ozarelix 62 PROMUS TM 62 Sipuleucel T 62 Post Herpetic Neuralgia 62 Vaccine Candidate 62 Infected Patients 62 Previously Treated 62 Fibrosis 62 Study Shows Benefits 62 Announce License Agreement 62 Endovascular Treatment 62 Computed Tomographic 62 Endoluminal 62 Hepatitis C Genotype 62 Frontotemporal Dementia 62 SUTENT ® 62 Inhalation Solution 62 Intravesical 62 ST Elevation Myocardial 62 Fracture Risk 62 Randomized Clinical Trial 62 Myocardial Perfusion Imaging 62 Fatty Liver 62 Pivotal Phase II 62 Milestone Payments 62 Silodosin 62 Syncria R 62 acetonide FA 62 Invasive Breast Cancer 62 Accelerated Partial Breast Irradiation 62 Endovascular Repair 62 Osteoporosis Drugs 62 Poster Presentations 62 Therapeutic Targets 62 Epithelial 62 Chronic Kidney 62 Demonstrates Statistically Significant 62 Controlled Study 62 Kidney Transplant Recipients 62 Iron Deficiency Anemia 62 Receptor Agonist 62 Helps Diagnose 62 Oncolytic 62 Bayer Onyx 62 Receptor Antagonists 62 Presents Positive 62 Nephropathy 62 PF # [002] 62 Erectile Dysfunction Drug 62 Randomized Controlled Trials 62 Relapsing Multiple Sclerosis 62 Cutaneous T 62 Microplasmin 62 Pharmacokinetic Study 62 refractory chronic lymphocytic 62 INS# [002] 62 Dendritic Cells 62 GRNCM1 62 Significantly Reduces 62 Metabolic Endocrinology 62 Polymerase Inhibitor 62 Acute Liver Failure 62 Multiple Myeloma Patients 62 Chronic Prostatitis 62 Unresectable 62 Inflammatory Response 62 Denufosol 62 Vertebral Fractures 62 Vaccine Protects Against 62 Anti Tumor Activity 62 Levels Linked 62 Excessive Sweating 62 Proteasome 62 Therapeutic Potential 62 Mucosal 62 Pandemic Influenza Vaccines 62 Osteoarthritis Patients 62 Follicular Lymphoma 62 Sirolimus Eluting Stent 62 hyaluronidase enzyme 62 Treating Depression 62 Presents Preclinical 62 Ultrasound Guided 62 Peripheral Artery Disease 62 Ebola Vaccine 62 targeted nucleotide prodrug 62 CyberKnife Radiosurgery 62 beta 1a 62 AMEX RGN 62 Mipomersen 62 Muscle Function 62 Hormone Replacement 62 Artificial Disc 62 AOD# [002] 62 Insulin Resistance 62 VentiRx Pharmaceuticals 62 Diagnosis Treatment 62 LibiGel ® 62 interstitial cystitis IC 62 Interferon beta 1a 62 Autologous Stem Cell Transplantation 62 Electrical Stimulation 62 Treating Heart Failure 62 Hematopoietic Stem Cells 62 AFREZZA TM 62 Dose Escalation 62 KL4 Surfactant 62 Hepatitis B Vaccine 62 Newly Identified 62 Study Demonstrates 62 Platelet Rich Plasma 62 Hepatitis Virus 62 Osteoporosis Treatment 62 Angioedema 62 Benign Prostatic Hyperplasia 61 Dapagliflozin 61 ALN PCS 61 Viral Infections 61 Pyridorin 61 Pemphigus Vulgaris 61 Irbesartan 61 R lenalidomide 61 Stress Incontinence 61 Decompensated Heart Failure 61 Bisphosphonate 61 Nesiritide 61 Metastatic Prostate Cancer 61 Prostate Cancer Diagnosis 61 Glomerular 61 Patient Enrolment 61 Acute Treatment 61 Dacogen decitabine 61 Carotid Endarterectomy 61 occlusion PAO 61 Zenvia Phase III 61 Squamous Cell Carcinoma 61 Acute Exacerbations 61 Primary Immunodeficiency 61 Tacrolimus 61 Genital Herpes 61 Anticancer Activity 61 Androgen Deprivation Therapy 61 essential thrombocythemia ET 61 Growth Hormone Deficiency 61 Guidelines Recommend 61 Smallpox Vaccine 61 Randomized Double blind 61 Microvolt T Wave Alternans 61 Shows Promising 61 DURIN TM 61 Pegylated Liposomal Doxorubicin 61 Microalbuminuria 61 Vernakalant 61 Tissue Repair 61 Molecular Diagnostic 61 MYCAMINE 61 Chronic Lymphocytic Leukemia CLL 61 ARIXTRA R 61 ThermoDox R 61 Oral Cladribine 61 Oral Presentations 61 Phase 2a Study 61 Proves Successful 61 Genes Associated 61 Crit Rev 61 myoblast therapy 61 Adaptive Radiation Therapy 61 Trodusquemine MSI 61 Glatiramer acetate 61 Exacerbation 61 Extracorporeal Shock Wave 61 Delcath Phase III 61 Cancer Vaccines 61 Cancer Treatments 61 Molecular Mechanisms 61 Malignancies 61 acyclovir Lauriad R 61 Package Insert 61 Bone Fracture 61 Male Infertility 61 Chelation Therapy 61 Respiratory Syncytial Virus 61 Metastatic Colorectal Cancer 61 Vascular Disrupting Agent 61 Resection 61 Double Blind Randomized 61 Archexin 61 Cholesterol Drug 61 Contrast Enhanced 61 Bacteremia 61 Pancreatic 61 Diabetic Foot Ulcers 61 Prognostic Factors 61 TM Everolimus Eluting 61 Immune Cells 61 Natalizumab 61 Coronary Angiography 61 Polymorphisms 61 PrevOnco 61 Pirfenidone 61 Immunomedics Announces 61 hypereosinophilic syndrome 61 Chronic HCV 61 Submits Investigational 61 TLK# 61 Intracranial Aneurysms 61 Endothelial 61 orally administered inhibitor 61 Ovarian Cancers 61 Nebulized 61 Patients Suffering 61 Lung Cancer Treatment 61 Diet Linked 61 Bayer HealthCare Onyx Pharmaceuticals 61 EnteroMedics proprietary neuroblocking technology 61 Transcription Factor 61 Autoimmune Disorders 61 Toremifene 61 Serostim ® 61 Metastases 61 injectable bulking agent 61 Stomach Cancer 61 Patient Registry 61 Bladder Cancer 61 Treatment Resistant 61 pentostatin 61 ATPace TM 61 Completes Dosing 61 Targeted Therapy 61 Pelvic Organ Prolapse 61 Aviptadil 61 Preclinical Models 61 C1 Inhibitor 61 Oncologic 61 malignant ascites 61 Angiox ® 61 adult mesenchymal stem 61 Molecular Mechanism 61 Image Guided 61 Immune Responses 61 Cotara ® 61 Epitope 61 Frozen Shoulder Syndrome 61 Successfully Treated 61 nephropathic cystinosis 61 PHRM 61 thrombolytic agent 61 J Am Coll 61 NAVISTAR R 61 Virus Linked 61 Critical Limb Ischemia CLI 61 Pancreas Cancer 61 Inhaled Liposomal Ciprofloxacin 61 Oxybutynin 61 FASLODEX 61 Rotary VAD 61 Lung Cancer Patients 61 Therapeutic Vaccines 61 Adjuvant Breast Cancer 61 Antitumor 61 complement inhibitor eculizumab 61 Bone Marrow Stem Cell 61 LymphoStat B belimumab 61 STENT 61 Critically Ill Patients 61 Circulating Tumor Cells 61 Mg Usa 61 Observational Study 61 Osteoporosis Drug 61 Resten NG 61 Hospital Acquired Pneumonia 61 XYOTAX TM 61 DUROS 61 Submits IND 61 Phase III Clinical Trials 61 Selective Internal